The effect of IL-28A on human cord blood CD4⁺ T cells

References

• Laughlin MJ, Eapen M, Rubinstein P, Wagner J.E, Zhang MJ, Champlin RE, et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med 2004;351(22):2265–2275.
   PubMedGoogle Scholar
• Koh LP, Chao NJ. Umbilical cord blood transplantation in adults using myeloablative and nonmyeloablative preparative regimens. Biol Blood Marrow Transplant 2004;10(1):1–22.
   PubMedGoogle Scholar
• Gluckman, E, Rocha, V, Boyer-Chammard, A, Locatelli, F, Arcese, W, Pasquini, R, et al.Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N Engl J Med 1997;337(6):373–381.
   PubMedGoogle Scholar
• Petropoulos D, Chan KW. Umbilical cord blood transplantation. Curr Oncol Rep 2005;7(6):406–409.
   PubMedGoogle Scholar
• Fruchtman S.Stem cell transplantation. Mt. Sinai J Med 2003;70(3):166–170.
   PubMedGoogle Scholar
• Han, P, Hodge, G, Story, C, Xu X. Phenotypic analysis of functional T-lymphocyte subtypes and natural killer cells in human cord blood: relevance to umbilical cord blood transplantation. Br J Haematol 1995;89(4):733–740.
   PubMedGoogle Scholar
• Wood KJ, Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol 2003;3(3):199–210.
   PubMedGoogle Scholar
• Asano M, Toda M, Sakaguchi N, Sakaguchi S. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J Exp Med 1996;184(2):387–396.
   PubMed Web of Science ®Google Scholar
• Kotenko SV, Gallagher G, Baurin VV, Lewis-Antes A, Shen ML, Shah NK, et al. IFN-lambda s mediate antiviral protection through a distinct class II cytokine receptor complex. Nature Immunol 2003;4(1):69–77.
   PubMedGoogle Scholar
• Sheppard P, Kindsvogel W, Xu WF, Henderson K, Schlutsmeyer S, Whitmore TE, et al.,?et al. IL-28, IL-29 and their class II cytokine receptor IL-28R. Nature Immunol 2003;4(1):63–68.
   PubMedGoogle Scholar
• Lasfar A, Lewis-Antes A, Smirnov SV, Anantha S, Abushahba W, Tian B, et al. Characterization of the mouse IFN-lambda ligand-receptor system: IFN-lambda s exhibit antitumor activity against B16 melanoma. Cancer Res 2006;66(8):4468–4477.
   PubMedGoogle Scholar
• Coccia EM, Severa M, Giacomini E, Monneron D, Remoli ME, Julkunen I, et al. Viral infection and Toll-like receptor agonists induce a differential expression of type I and lambda interferons in human plasmacytoid and monocyte-derived dendritic cells. Eur J Immunol 2004;34(3):796–805.
   PubMedGoogle Scholar
• Dumoutier, L, Lejeune, D.; Hor S, Fickenscher H, Renauld JC. Cloning of a new type II cytokine receptor activating signal transducer and activator of transcription (STAT)1, STAT2 and STAT3. Biochem J2003;370:391–396.
   PubMed Web of Science ®Google Scholar
• Donnelly RP, Sheikh F, Kotenko SV, Dickensheets H. The expanded family of class II cytokines that share the IL-10 receptor-2 (IL-10R2) chain. J Leukocyte Biol 2004;76(2):314–321.
   PubMedGoogle Scholar
• Meager A, Visvalingam K, Dilger P, Bryan D, Wadhwa M. Biological activity of interleukins-28 and-29: Comparison with type I interferons. Cytokine 2005;31(2):109–118.
   PubMedGoogle Scholar
• Jordan WJ, Eskdale J, Srinivas S, Pekarek V, Kelner D, Rodia M, et al.Human interferon lambda-1 (IFN-lambda 1/IL-29) modulates the Th1/Th2 response. Genes Immun 2007;8(3): 254–261.
   PubMedGoogle Scholar
• Dumoutier L, Tounsi A, Michiels T, Sommereyns C, Kotenko SV, Renauld JC. Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-lambda 1—similarities with type I interferon signaling. J BiologChem 2004;279(31):32269–32274.
   PubMedGoogle Scholar
• Langer JA, Cutrone EC, Kotenko S. The Class II cytokine receptor (CRF2) family: overview and patterns of receptor-ligand interactions. Cytokine Growth Factor Revs 2004;15(1):33–48.
   PubMedGoogle Scholar
• Brand, S, Beigel F, Olszak T, Zitzmann K, Eichhorst ST, Otte J.M, Diebold J, et al. IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression. Am J Physiol Gastrointest Liver Physiol 2005;289(5):G960–G968.
   PubMedGoogle Scholar
• Zitzmann K, Brand S, Baehs S, Goke B, Meinecke J, Spottl G, et al. Novel interferon-lambda s induce antiproliferative effects in neuroendocrine tumor cells. Biochem Biophys Res Comms 2006;344(4):1334–1341.
   PubMedGoogle Scholar
• Ank N, West H, Paludan, SR. IFN-lambda: novel antiviral cytokines. J Interferon Cytokine Res 2006;26(6):373–379.
   PubMedGoogle Scholar
• Melchjorsen J, Siren J, Julkunen K, Paludan SR, Matikainen S. Induction of cytokine expression by herpes simplex virus in human monocyte-derived macrophages and dendritic cells is dependent on virus replication and is counteracted by ICP27 targeting NF-kappa B and IRF-3. J Gen Virol 2006;87:1099–1108.
   PubMed Web of Science ®Google Scholar
• Sato A, Ohtsuki M, Hata M, Kobayashi E, Murakami T. Antitumor activity of IFN-lambda in murine tumor models. J Immunol 2006;176(12):7686–7694.
   PubMedGoogle Scholar
• Chi B, Dickensheets HL, Spann KM, Alston MA, Luongo C, Dumoutier L, et al. Alpha and lambda interferon together mediate suppression of CD4 T cells induced by respiratory syncytial virus. J Virol 2006;80(10):5032–5040.
   PubMedGoogle Scholar
• Mennechet FJD, Uze G. Interferon-lambda-treated dendritic cells specifically induce proliferation of Foxp3-expressing suppressor T cells. Blood 2006;107(11):4417–4423.
   PubMedGoogle Scholar
• de Waal MR, Haanen J, Spits H, Roncarolo MG, Te VA, Figdor C et al. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 1991;174(4):915–924.
   PubMedGoogle Scholar
• de Waal MR, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991;174(5):1209–1220.
   PubMedGoogle Scholar
• Groux H, Bigler M, de Vries JE, Roncarolo MG. Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells. J Exp Med 1996;184(1):19–29.
   PubMedGoogle Scholar
• Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA. CD4+CD25(high) regulatory cells in human peripheral blood. J Immunol 2001;167(3):1245–1253.
   PubMedGoogle Scholar
• Fontenot JD, Rasmussen JP, Williams LM, Dooley JL, Farr AG, Rudensky AY. Regulatory T cell lineage specification by the forkhead transcription factor Foxp3. Immunity 2005;22(3):329–341.
   PubMedGoogle Scholar
• Koenen HJPM, Fasse E, Joosten I. CD27/CFSE based ex vivo selection of highly suppressive alloantigen-specific human regulatory T cells. Am J Transplant 2005;5:361.
   Google Scholar
• Walker MR, Kasprowicz DJ,Gersuk VH, Benard A, Van Landeghen M, Buckner JH, Ziegler, SF. Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4(+)CD25(-) T cells. J Clin Invest 2003;112(9):1437–1443.
   PubMedGoogle Scholar
• Yagi H, Nomura T, Nakamura K, Yamazaki S, Kitawaki T, Hori S, et al. Crucial role of FOXP3 in the development and function of human CD25(+)CD4(+) regulatory T cells. Intern Immunol 2004;16 (11):1643–1656.
   PubMedGoogle Scholar
• Li W, Lewis-Antes A, Huang J, Balan M, Kotenko SV. Regulation of apoptosis by type III interferons. Cell Prolif 2008;41(6):960–979.
   PubMedGoogle Scholar
• Allan SE, Crome SQ, Crellin NK, Passerini L, Steiner TS, Bacchetta R, et al. Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Intern Immunol 2007;19(4):345–354.
   PubMedGoogle Scholar
• Nelson BH. Willerford DM. Biology of the interleukin-2 receptor. Adv Immunol1998;70:1–81.
   PubMed Web of Science ®Google Scholar
• Shevach EM. From vanilla to 28 flavors: multiple varieties of T regulatory cells. Immunity 2006;25(2):195–201.
   PubMedGoogle Scholar
• Tran D.Q, Ramsey H, Shevach EM. Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype. Blood 2007;110(8):2983–2990.
   PubMedGoogle Scholar
• Mahic M, Yaqub S, Johansson CC, Tasken K, Aandahl EM. FOXP3(+)CD4(+)CD25(+) adaptive regulatory T cells express cyclooxygenase-2 and suppress effector T cells by a prostaglandin E-2-dependent mechanism. J Immunol 2006;177(1):246–254.
   PubMedGoogle Scholar
• Mahic M, Yaqub S, Bryn T, Henjum K, Eide DM, Torgersen KM, Aandahl, EM, Tasken, K. Differentiation of naive CD4+ T cells into CD4+CD25+FOXP3+ regulatory T cells by continuous antigen stimulation. J Leukocyte Biol 2008;83(5):1111–1117.
   PubMedGoogle Scholar
• Walker MR, Carson BD, Ziegler SF, Nepom GT, Buckner JH. De novo generation of antigen-specific CD4+CD25+ regulatory T cells from human CD4+CD25- cells. Proc Natl Acad Sci 2005; 102(11):4103–4108.
   Google Scholar